Figure 2 shows all 74 recurrently mutated genes (mutated in ≥2 samples) with FLT3 (90/168, 54%), NPM1 (56/168, 33%), WT1 (42/168, 25%), NRAS (39/168, 23%), and CEBPA (31/168, 18%) as the top five most commonly mutated genes in NK-AML. This evidence concerns the gene CEBPA and acute myeloid leukemia.